Navigation Links
Survey Finds U.S. Healthcare Facilities Not Doing Enough to Curb MRSA
Date:12/11/2007

ious estimates had indicated. The report found that the antibiotic-resistant bacteria are found in all wards throughout most hospitals. See: http://journals.elsevierhealth.com/periodicals/ymic/article/PIIS01966553070 07729/abstract

In October, the Centers for Disease Control and Prevention (CDC) estimated that nearly 95,000 developed MRSA infections in 2005 and almost 19,000 people died. CDC research indicates that 85 percent of these infections are picked up by patients exposed to MRSA in hospitals and other healthcare settings, like nursing homes and dialysis centers.

APIC's most recent survey found that 41 percent of infection control professionals said their healthcare facility had not taken any new prevention measures since the MRSA prevalence study was published in June. Of these respondents, 19 percent said there were "no resources to change their approach" while 33 percent noted other reasons such as the "lack of support from hospital leadership, not enough staff and lack of time."

Of those who reported that not enough was being done to curb MRSA, most wanted their healthcare facilities to screen high-risk patients for MRSA, improve hand hygiene, and increase the use of gloves and gowns with patients who test positive for MRSA.

Many hospitals in northern Europe have used these strategies to successfully control MRSA for decades. A pilot program employing MRSA screening and additional precautions at the VA Pittsburgh Healthcare System in Pennsylvania in 2001 has reduced infections in the hospital's surgical unit by 70 percent. The program proved so successful that it is now being implemented in all VA hospitals nationwide.

Numerous studies have shown that this approach helps save money by preventing infections that would result in even higher costs for the patient and hospital. A recent analysis found that hospit
'/>"/>

SOURCE Consumers Union
Copyright©2007 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine technology :

1. Nationwide Survey Reports that Mothers View Cleaning Homes and Toys as Essential to Preventing Colds & Flu
2. Replikins LLC Finds West Nile Virus Replikin Count Has Reached Its Highest Recorded Value
3. First Osteoporosis Study in Hip Fracture Patients Finds Once-Yearly Reclast(R) Prevents Additional Fractures and Improves Survival
4. Mayo Clinic Study Finds FDA Warning Against Anti-Nausea Drug Droperidol Unnecessary
5. Review of Probiotic Trial Research Finds Only Bifantis(R) Able to Claim Efficacy versus Placebo for IBS Symptoms
6. New Report by Pediatricians Finds Gaps in Preparing to Protect Kids From Pandemic Flu, Offers Recommendations
7. UPDATE: New Report by Pediatricians Finds Gaps in Preparing to Protect Kids From Pandemic Flu, Offers Recommendations
8. Study Finds Starion Instruments Tissue Welding Technology Reduces Pain and Bleeding in Tonsillectomy Patients
9. Providence Hospital Study Finds Communication System Leads to Faster Heart Attack Treatment
10. Retrospective Analysis Finds That Initiation of Insulin Glargine in Patients With Type 2 Diabetes was Associated With a Lower Incidence Rate of Myocardial Infarction as Compared With NPH Insulin
11. St. Jude Finds Molecule That Could Improve Cancer Vaccine and Therapy for Other Diseases
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/16/2009)... MAQUET Cardiovascular LLC, a leading provider of ... signed a three-year single source provider contract ... company, for MAQUET,s market-leading VASOVIEW Endoscopic Vessel ... healthcare providers in obtaining veins for repair ... incisions. This allows for faster healing, less ...
(Date:12/16/2009)... Inc., a new clinical stage company developing innovative ... on its novel GFPA NMDA receptor modulators, today ... meeting showed that its lead compound GLYX-13 demonstrated ... of the CNS-related side effects seen with other ... also showed that GLYX-13,s antidepressant effects were evident ...
(Date:12/16/2009)... Keryx Biopharmaceuticals, Inc. (Nasdaq: ... a Phase 3 registration clinical trial for ... in relapsed / refractory multiple myeloma patients. ... Randomized Study to Assess the Efficacy and ... of Bortezomib (Velcade®) and Dexamethasone in Multiple ...
Breaking Medicine Technology:MAQUET Cardiovascular Awarded Three-Year Single Source Contract From Novation for VASOVIEW Endoscopic Vessel Harvesting Devices 2MAQUET Cardiovascular Awarded Three-Year Single Source Contract From Novation for VASOVIEW Endoscopic Vessel Harvesting Devices 3MAQUET Cardiovascular Awarded Three-Year Single Source Contract From Novation for VASOVIEW Endoscopic Vessel Harvesting Devices 4Naurex Inc. Announces Presentation of Preclinical Data Showing its Novel Mechanism NMDA Modulator Exhibits Robust and Rapid-Onset Antidepressant Activity With No Signs of Classic NMDA-Associated Side Effects 2Naurex Inc. Announces Presentation of Preclinical Data Showing its Novel Mechanism NMDA Modulator Exhibits Robust and Rapid-Onset Antidepressant Activity With No Signs of Classic NMDA-Associated Side Effects 3Naurex Inc. Announces Presentation of Preclinical Data Showing its Novel Mechanism NMDA Modulator Exhibits Robust and Rapid-Onset Antidepressant Activity With No Signs of Classic NMDA-Associated Side Effects 4Naurex Inc. Announces Presentation of Preclinical Data Showing its Novel Mechanism NMDA Modulator Exhibits Robust and Rapid-Onset Antidepressant Activity With No Signs of Classic NMDA-Associated Side Effects 5Naurex Inc. Announces Presentation of Preclinical Data Showing its Novel Mechanism NMDA Modulator Exhibits Robust and Rapid-Onset Antidepressant Activity With No Signs of Classic NMDA-Associated Side Effects 6Keryx Biopharmaceuticals, Inc. Initiates Phase 3 Registration Trial of KRX-0401 (Perifosine) for Treatment of Patients with Advanced Multiple Myeloma 2Keryx Biopharmaceuticals, Inc. Initiates Phase 3 Registration Trial of KRX-0401 (Perifosine) for Treatment of Patients with Advanced Multiple Myeloma 3Keryx Biopharmaceuticals, Inc. Initiates Phase 3 Registration Trial of KRX-0401 (Perifosine) for Treatment of Patients with Advanced Multiple Myeloma 4Keryx Biopharmaceuticals, Inc. Initiates Phase 3 Registration Trial of KRX-0401 (Perifosine) for Treatment of Patients with Advanced Multiple Myeloma 5Keryx Biopharmaceuticals, Inc. Initiates Phase 3 Registration Trial of KRX-0401 (Perifosine) for Treatment of Patients with Advanced Multiple Myeloma 6Keryx Biopharmaceuticals, Inc. Initiates Phase 3 Registration Trial of KRX-0401 (Perifosine) for Treatment of Patients with Advanced Multiple Myeloma 7Video 3A truth 28R 29 Asks 3A Do You Have What it Takes 3F 47479 1Video 3A truth 28R 29 Asks 3A Do You Have What it Takes 3F 47479 2Video 3A truth 28R 29 Asks 3A Do You Have What it Takes 3F 47479 3Video 3A truth 28R 29 Asks 3A Do You Have What it Takes 3F 47479 4S C BlueCross Makes Coverage Available for Thousands of South Carolina Graduates Lacking Health Insurance 47474 1S C BlueCross Makes Coverage Available for Thousands of South Carolina Graduates Lacking Health Insurance 47474 2Wet ear wax and unpleasant body odors signal breast cancer risk 8673 1Wet ear wax and unpleasant body odors signal breast cancer risk 8673 2
... many challenges in treating patients with cancer, treating ... quite difficult as studies,suggest that certain therapies can ... study prepublished today online in Blood, the official,journal ... treated with,imatinib, a commonly used therapy for chronic ...
... Memory Formula(TM), PURCHASE, N.Y., March 4 ... and marketer of nutritional supplements that,help consumers manage ... address chronic joint pain, today announced the results,of ... 1000 mcg of,chromium, as chromium picolinate, increased brain ...
Other Medicine Technology:Leukemia Therapy With Imatinib During Pregnancy May Cause Infant Abnormalities 2Leukemia Therapy With Imatinib During Pregnancy May Cause Infant Abnormalities 3New Clinical Data Further Supports Chromium Picolinate's Role in Enhancing Brain Activity in Older Adults 2New Clinical Data Further Supports Chromium Picolinate's Role in Enhancing Brain Activity in Older Adults 3New Clinical Data Further Supports Chromium Picolinate's Role in Enhancing Brain Activity in Older Adults 4
(Date:12/16/2009)... Boston University School of Medicine,s (BUSM) Pulmonary ... from the National Heart, Lung, and Blood Institute ... patients with lung disease. , Darrell Kotton, ... Gustavo Mostoslavsky, MD, PhD, assistant professor of medicine, ... award. Together Kotton and Mostoslavsky lead a multicenter ...
(Date:12/16/2009)... Global Market Expansion , ... Ramat-Gan, Israel (PRWEB) December ... to Web sites and companies, today announced a record year of ... Since its launch on July 2008, Kampyle has processed more than ... more than 30,000 customers in 191 countries., , ,Kampyle pioneered the ...
(Date:12/16/2009)... -- For ages, people from around the world have ... soothing waters have a reputation that dates back over ... miracles. Now, with the introduction of two bath salt ... the legendary benefits of Dead Sea salt in their ... all-natural Dead Sea salt and essential oils - but ...
(Date:12/16/2009)... WILMINGTON, Delaware, December 16 While ... outsource their accurate forecast models,for new and ... provides,integrated patient-based forecast solutions to various players. ... I, phase II, as well as phase,III. ... launch, product life cycle,management, market entry strategy, ...
(Date:12/16/2009)... has run marathons, competed in triathalons and appeared on ... -- Sarah Reinertsen likes to think of herself as part ... world is how the 34-year-old triathlete likes to describe herself. ... her speaking to packed school auditoriums or posing nude with ... the cover of the latest ESPN Body Issue. ...
Breaking Medicine News(10 mins):Health News:Boston University School of Medicine's pulmonary center receives $1.4 million grant 2Health News:Kampyle Experiences Record Growth in 2009 with 25,000 New Customers 2Health News:Kampyle Experiences Record Growth in 2009 with 25,000 New Customers 3Health News:Kampyle Experiences Record Growth in 2009 with 25,000 New Customers 4Health News:Kampyle Experiences Record Growth in 2009 with 25,000 New Customers 5Health News:SaltWorks Launches Two All-Natural Bath Salt Lines Featuring Therapeutic Salt from the Dead Sea 2Health News:SaltWorks Launches Two All-Natural Bath Salt Lines Featuring Therapeutic Salt from the Dead Sea 3Health News:MarketsandMarket's Integrated Patient-based Forecasting Solution for Pharmaceutical Industry, Mainly for Pipeline Products 2Health News:MarketsandMarket's Integrated Patient-based Forecasting Solution for Pharmaceutical Industry, Mainly for Pipeline Products 3Health News:Amputee Athlete Tells Her Story 2Health News:Amputee Athlete Tells Her Story 3Health News:Amputee Athlete Tells Her Story 4
... on health care,information technology will be speaking ... patient safety, HIT applications, privacy and,legislative activities ... be,held September 8-10, 2008, in Spokane, Washington. ... Physicians; John Glaser, PhD, Partners,Health Care; Micky ...
... Aug. 13 Wound Care,Innovations, LLC, a subsidiary ... is excited about expanding upon the announcement,that was ... independent case,reports utilizing their advanced wound care collagen ... Skin and Wound Care.,The case presentations were on ...
... Corporation,announced today that for the second quarter ended June ... million or 3 cents per share, on,revenues of $4.8 ... a consolidated net loss of $7.4 million, or 8 ... loss from continuing operations was $1.9 million for the ...
... working in more than 30,earthquake-affected communities in Peru, ... massive,earthquake struck this region last August 15th, it ... homeless.,Although the spotlight has moved on, the American ... the Peruvian Red Cross to help families rebuild,physically ...
... plan to significantly involve their workers in long-term strategies to control ... survey released today by Buck Consultants. , ... New ... their workers in long-term strategies to control prescription drug costs. This ...
... of The Blue Lion Foundation is raffling her tickets to see her ... of all ages to overcome challenges through persistence and determination. , ... ... tickets for her to The Jonas Brothers, she decided to give away ...
Other Medicine News:Health News:Wound Management Technologies, Inc. Announces Clarification of Eprint Viewing of Case Report in Advances in Skin and Wound Journal 2Health News:Westaim announces 2008 second quarter results 2Health News:Westaim announces 2008 second quarter results 3Health News:Westaim announces 2008 second quarter results 4Health News:One Year Later: Red Cross Helping Peru Earthquake Survivors Rebuild 2Health News:Employee Involvement Is Key to Long-Term Pharmacy Cost Control, Finds Buck Consultants Survey 2Health News:Employee Involvement Is Key to Long-Term Pharmacy Cost Control, Finds Buck Consultants Survey 3Health News:Employee Involvement Is Key to Long-Term Pharmacy Cost Control, Finds Buck Consultants Survey 4Health News:Pittsburgh Teen Raffles Her Jonas Brothers Tickets to Educate and Inspire 2Health News:Pittsburgh Teen Raffles Her Jonas Brothers Tickets to Educate and Inspire 3
100L...
... is precision, ergonomics, and value!, ... with soft non-slip, contoured handle , ... light plunger spring action , Completely ... without the need for recalibration , ...
Inquire...
... Focus from Thermo Labsystems was ... with uncompromising performance. The ... a custom fit for different ... tip cones allow easier and ...
Medicine Products: